| Press Release | Foundation Medicine Collaborates with Sumitomo Pharma America to Advance Investigational Treatment for Patients with Acute Leukemia with NPM1 Mutations or KMT2A Rearrangements Using the FoundationOneHeme Platform | Foundation Medicine | 0 | 1 month 1 week ago |
| Press Release | Foundation Medicine to Launch Hereditary Germline Tests, FoundationOneGermline and FoundationOneGermline More, in the United States Through a Partnership with Fulgent Genetics | Foundation Medicine | 0 | 1 month 3 weeks ago |
| Press Release | U.S. Food and Drug Administration Approves FoundationOneCDx as a Companion Diagnostic for OJEMDA (tovorafenib) to Treat the Most Common Form of Childhood Brain Tumor in Pediatric Patients | Foundation Medicine | 0 | 2 months 1 week ago |
| Press Release | Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezatapopt, a First-In-Class, Investigational, Selective p53 Y220C Reactivator | Foundation Medicine | 0 | 10 months 2 days ago |
| Press Release | Foundation Medicine Announces Details of Over 20 Presentations at the 2024 ASCO Annual Meeting | Foundation Medicine | 0 | 10 months 6 days ago |
| Press Release | Foundation Medicine Launches RNA Sequencing Test, FoundationOneRNA, in the U.S. | Foundation Medicine | 0 | 10 months 1 week ago |
| Press Release | Foundation Medicine Receives FDA Approval for FoundationOneLiquid CDx as a Companion Diagnostic for a Certain Group of Tyrosine Kinase Inhibitors for Treatment of Non-Small Cell Lung Cancer Patients | Foundation Medicine | 0 | 2 years 2 months ago |
| Press Release | Foundation Medicine Launches FoundationReport+, a New Digital Reporting Experience to Streamline Precision Cancer Care | Foundation Medicine | 0 | 2 years 4 months ago |
| Press Release | Foundation Medicine and Relay Therapeutics Collaborate to Develop FoundationOneCDx as a Companion Diagnostic for Relays Investigational FGFR2 Inhibitor, RLY-4008 | Foundation Medicine | 0 | 2 years 5 months ago |
| Press Release | Foundation Medicine to Share 14 Abstracts at the 2022 European Society for Medical Oncology (ESMO) Congress Demonstrating the Power of Genomic Profiling to Advance Cancer Care | Foundation Medicine | 0 | 2 years 5 months ago |
| Press Release | Foundation Medicine and Day One Biopharmaceuticals Announce Global Collaboration to Advance Pediatric Cancer Care | Foundation Medicine | 0 | 2 years 5 months ago |
| Press Release | Foundation Medicine Partners with Lung Cancer Research Foundation and the Lung Cancer Mutation Consortium on Screening Trial to Enable Precision Therapy | Foundation Medicine | 0 | 2 years 9 months ago |
| Press Release | Foundation Medicine Announces Strategic Collaboration with Arvinas | Foundation Medicine | 0 | 2 years 9 months ago |
| Press Release | U.S. FDA Approves FoundationOneCDx as a Companion Diagnostic for Rozlytrek (entrectinib) | Foundation Medicine | 0 | 2 years 9 months ago |
| Press Release | U.S. FDA Approves FoundationOneCDx as a Companion Diagnostic for EGFR Therapeutics Targeting Exon 19 Deletions or Exon 21 Substitutions in Non-Small Cell Lung Cancer | Foundation Medicine | 0 | 2 years 10 months ago |
| Press Release | U.S. FDA Approves FoundationOneCDx as a Companion Diagnostic for KEYTRUDA (pembrolizumab) to Identify Patients with Microsatellite Instability-High (MSI-H) Solid Tumors | Foundation Medicine | 0 | 3 years 1 month ago |
| Press Release | Foundation Medicines ctDNA Monitoring Assay, FoundationOneTracker, Granted Breakthrough Device Designation by U.S. Food and Drug Administration | Foundation Medicine | 0 | 3 years 1 month ago |
| Press Release | Foundation Medicine Announces Global Collaboration With Lilly to Develop FoundationOneCDx and FoundationOneLiquid CDx as Companion Diagnostics for RETEVMO and Loxo Oncology at Lillys Pipeline Programs | Foundation Medicine | 0 | 3 years 1 month ago |
| Press Release | FoundationOneCDx Receives FDA Approval as a Companion Diagnostic for BRAF Inhibitor Therapeutics in Melanoma | Foundation Medicine | 0 | 3 years 3 months ago |
| Press Release | Foundation Medicine Now an In-Network Provider for Humana Military and Health Net Federal Services | Foundation Medicine | 0 | 3 years 4 months ago |
| Press Release | Foundation Medicine Appoints Dymeka Harrison as Chief Commercial Officer | Foundation Medicine | 0 | 3 years 5 months ago |
| Press Release | Foundation Medicine Appoints Mia Levy, MD, PhD as Chief Medical Officer | Foundation Medicine | 0 | 3 years 6 months ago |
| Press Release | Science 37 and Foundation Medicine Partner to Enable Interventional Home-Based Clinical Trials in Oncology | Foundation Medicine | 0 | 3 years 6 months ago |
| Press Release | Foundation Medicine Launches FoundationOneTracker ctDNA Monitoring Assay for Research Use in Partnership with Natera | Foundation Medicine | 0 | 3 years 6 months ago |
| Press Release | New Study Results Presented by Foundation Medicine and Collaborators at ASCO21 on Ancestry-Based Disparities in Prostate Cancer Care Underscore Importance of Equitable Access to Precision Medicine Advances | Foundation Medicine | 0 | 3 years 6 months ago |
